Friday, August 24, 2012

Last-hope prostate drug not funded | London | News | London Free Press

Link: (via

Zytiga (Abiraterone Acetate)
  • Pills taken daily with few side effects.
  • Health Canada OK'd July 2011. Every province but Ontario funds it.
  • Extends life an average four months and reduces pain.
--- --- ---
Letter from Ontario Health Ministry to patient denying coverage:
"Although there is a well-conducted randomized controlled trial demonstrating a statistically and clinically significant increase in overall survival without substantial side effects in this group of patients . . . the cost effectiveness of this agent is not favourable. As a result, the (Committee to Evaluate Drugs) recommended that Zytiga not be funded."
The cost?  $5000/month.  (Don't know if that's $US or $Can.)

No comments: